There has been incessant rise in prevalence of atrial fibrillation and other heart-related medical conditions such as valvular heart diseases and number of hypertension patients. These factors are primarily attributed to growth of Electrophysiology/Atrial Fibrillation market. The report “Global Electrophysiology/Atrial Fibrillation Ablation Market Outlook 2022” provides an in-depth analysis of global electrophysiology/atrial fibrillation market.
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global electrophysiology/atrial fibrillation ablation market. The report has been segmented as following:-
Market Segmentation
 By Products
 EP Ablation Catheters
 EP Diagnostic Catheters
 Cardiac Monitors
 By Application
 EP Monitoring Devices
 EP Treatment Devices
Key Vendors
 Medtronic Plc
 Biosense Webster, Inc.
 Abbott Laboratories
 Boston Scientific Corporation